ArticleMolecular therapy. Methods & clinical development2023

CRISPR-Cas9-mediated somatic correction of a one-base deletion in the Ugt1a gene ameliorates hyperbilirubinemia in Crigler-Najjar syndrome mice.

Giulia Bortolussi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.